BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7944004)

  • 61. The relationship between plasma thrombospondin level and the clinical course of atopic dermatitis.
    Huang SW; Kao KJ
    Allergy Proc; 1993; 14(5):357-61. PubMed ID: 8288118
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Inflammatory mediators in patients with atopic dermatitis after treatment with transfer factor].
    Orozco TT; Solano MO; Sandoval GF; Vera JG; Parra SE
    Rev Alerg Mex; 2004; 51(4):151-4. PubMed ID: 15491080
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Levels of soluble ICAM-1 are slightly elevated in the serum of patients with atopic dermatitis.
    Wüthrich B; Joller-Jemelka HJ; Kägi M
    Int Arch Allergy Immunol; 1996 Jul; 110(3):298. PubMed ID: 8688678
    [No Abstract]   [Full Text] [Related]  

  • 64. Levels of soluble ICAM-1 in atopic dermatitis. A new marker for monitoring the clinical activity?
    Wüthrich B; Joller-Jemelka H; Kägi MK
    Allergy; 1995 Jan; 50(1):88-9. PubMed ID: 7741194
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circulating activation markers of severe atopic dermatitis following ultraviolet A1 cold light phototherapy: eosinophil cationic protein, soluble interleukin-2 receptor and soluble interleukin-4 receptor.
    von Kobyletzki G; Pieck C; Höxtermann S; Freitag M; Altmeyer P
    Br J Dermatol; 1999 May; 140(5):966-8. PubMed ID: 10354046
    [No Abstract]   [Full Text] [Related]  

  • 66. Genotypic and phenotypic characterization of Staphylococcus aureus strains isolated in subjects with atopic dermatitis. Higher prevalence of exfoliative B toxin production in lesional strains and correlation between the markers of disease intensity and colonization density.
    Capoluongo E; Giglio A A; Lavieri MM; Lesnoni-La Parola I; Ferraro C; Cristaudo A; Belardi M; Leonetti F; Mastroianni A; Cambieri A; Amerio P; Ameglio F
    J Dermatol Sci; 2001 Jun; 26(2):145-55. PubMed ID: 11378332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low dose versus medium dose UV-A1 treatment in severe atopic eczema.
    Kowalzick L; Kleinheinz A; Weichenthal M; Neuber K; Köhler I; Grosch J; Lungwitz G; Seegeberg C; Ring J
    Acta Derm Venereol; 1995 Jan; 75(1):43-5. PubMed ID: 7538257
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Tissue eosinophilia and local deposition of eosinophil-specific granule proteins. Regulation and significance for inflammatory response in atopic dermatitis and other inflammatory dermatoses].
    Kiehl P; Kapp A
    Hautarzt; 1998 Mar; 49(3):176-83. PubMed ID: 9565784
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Elevation of serum-soluble E-selectin in atopic dermatitis.
    Morita H; Kitano Y; Kawasaki N
    J Dermatol Sci; 1995 Sep; 10(2):145-50. PubMed ID: 8534613
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduced level of soluble ICAM-1 in the serum of patients with atopic dermatitis.
    Yamada H; Chihara J; Tezuka T
    Int Arch Allergy Immunol; 1995 Oct; 108(2):203. PubMed ID: 7549511
    [No Abstract]   [Full Text] [Related]  

  • 71. Blood eosinophilia in atopic dermatitis.
    Uehara M; Izukura R; Sawai T
    Clin Exp Dermatol; 1990 Jul; 15(4):264-6. PubMed ID: 2208775
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IL-16 serum level in children with atopic dermatitis.
    Belloni Fortina A; Tonin E; Pigozzi B; Romano I; Michelotto G; Alaibac M
    Int J Immunopathol Pharmacol; 2006; 19(4):841-5. PubMed ID: 17166405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increased serum nitrate levels in infants with atopic dermatitis.
    Taniuchi S; Kojima T; Hara Mt K; Yamamoto A; Sasai M; Takahashi H; Kobayashi Y
    Allergy; 2001 Jul; 56(7):693-5. PubMed ID: 11421931
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.
    Wüthrich B; Kägi MK; Joller-Jemelka H
    Arch Dermatol Res; 1992; 284(6):339-42. PubMed ID: 1284103
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urinary eosinophil protein X in children with atopic dermatitis: relation to atopy and disease activity.
    Oymar K; Bjerknes R
    Allergy; 2000 Oct; 55(10):964-8. PubMed ID: 11030379
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Elevated levels of soluble HLA class I (sHLA-I) in children with severe atopic dermatitis.
    Moore C; Ehlayel M; Inostroza J; Leiva LE; Sorensen RU
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):113-8. PubMed ID: 9291414
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A role for eosinophils in atopic dermatitis.
    Leiferman KM
    J Am Acad Dermatol; 2001 Jul; 45(1 Suppl):S21-4. PubMed ID: 11423867
    [No Abstract]   [Full Text] [Related]  

  • 78. Changes in serum lactate dehydrogenase activity in children with atopic dermatitis.
    Morishima Y; Kawashima H; Takekuma K; Hoshika A
    Pediatr Int; 2010 Apr; 52(2):171-4. PubMed ID: 19519671
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Eosinophils increase neuron branching in human and murine skin and in vitro.
    Foster EL; Simpson EL; Fredrikson LJ; Lee JJ; Lee NA; Fryer AD; Jacoby DB
    PLoS One; 2011; 6(7):e22029. PubMed ID: 21811556
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Humoral immunity in atopic dermatitis. II. Serum immunoglobulins A, G and M in the blood of patients with atopic dermatitis].
    Przyk K; Ruszczak Z; Czarnecki M
    Przegl Dermatol; 1980; 67(6):729-33. PubMed ID: 7244251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.